This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Walgreens Names Mark Lelinski Corporate Vice President Of Market Access

Walgreens (NYSE: WAG) (Nasdaq: WAG) has named Mark Lelinski as its new corporate vice president, market access. Lelinski will be responsible for contracting and pricing strategies, integration efforts across Walgreens pharmacy, health and wellness division, sales and account management, and overseeing the continued evolution of the company’s managed market strategies. He joined Walgreens on June 17.

“Mark is a seasoned leader with an established track record of delivering results, and will help to build upon the excellent work that is being done in our market access group,” said Kermit Crawford, Walgreens president of pharmacy, health and wellness. “His experience in managed market roles both in the U.S. and internationally is the right fit for where Walgreens is headed. As a strategic partner of choice in the health care industry, we believe Mark’s relationship-driven approach will help us strengthen our partnerships and create more value from the emerging models and markets that will be key to our growth moving forward.”

Lelinski previously spent nine years with AstraZeneca in a number of marketing, strategy and managed market roles, both in the U.S. and abroad. In his most recent role as vice president, Americas region marketing and sales, Lelinski was responsible for implementing new commercial capabilities across markets in the U.S., Canada and Latin America. He also led efforts to build new capabilities in Latin America to improve both market access and patient affordability for the emerging middle class. As vice president, U.S. managed markets, Lelinski led all aspects of payer strategy, B2B marketing, account management, contracting and pricing with all payer customers.

Prior to joining AstraZeneca, Lelinski was a partner at Accenture, where he headed the pharmaceutical marketing and sales effectiveness practice. He also worked in a number of executive roles supporting physician networks, health plans and health informatics companies.

About Walgreens

As the nation's largest drugstore chain with fiscal 2012 sales of $72 billion, Walgreens ( www.walgreens.com) vision is to become America’s first choice for health and daily living. Each day, Walgreens provides more than 6 million customers the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice in communities across America. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with respiratory services. These services improve health outcomes and lower costs for payers including employers, managed care organizations, health systems, pharmacy benefit managers and the public sector. The company operates 8,098 drugstores in all 50 states, the District of Columbia and Puerto Rico. Take Care Health Systems is a Walgreens subsidiary that is the largest and most comprehensive manager of worksite health and wellness centers and in-store convenient care clinics, with more than 700 locations throughout the country.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,160.22 +118.68 0.66%
S&P 500 2,117.33 +13.13 0.62%
NASDAQ 5,075.2360 +42.4850 0.84%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs